U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039123) titled 'Polygenic Risk Score for Optimizing Primary Prevention in Intermediate-Risk Populations' on June 18.
Brief Summary: The goal of this clinical trial is to determine whether incorporating a polygenic risk score (PRS) can optimize primary cardiovascular disease prevention in individuals with intermediate cardiovascular risk.
The main questions it aims to answer are:
* Can a polygenic risk score improve risk stratification in intermediate-risk individuals?
* Does disclosing polygenic risk information to patients and physicians lead to better preventive interventions (e.g., statin use, lifestyle changes)? Researchers will compare outc...